Public Sector Pension Investment Board (PSP Investments)
DAWN

Public Sector Pension Investment Board (PSP Investments)’s Day One Biopharmaceuticals DAWN Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.06M Buy
+236,000
New +$3.33M 0.02% 881

Other funds holding DAWN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s DAWN Position: Q1 2026 in Review

Public Sector Pension Investment Board (PSP Investments) opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 236,000 shares worth $5.06M. The stake represents 0.02% of the portfolio and ranks #881 among its holdings.

207 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 236,000 shares of Day One Biopharmaceuticals worth $5.06M as of Q1 2026.
  • Day One Biopharmaceuticals was a new Public Sector Pension Investment Board (PSP Investments) position in Q1 2026.
  • Day One Biopharmaceuticals made up 0.02% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q1 2026, its #881 holding.
  • 207 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2026, filed 13 May 2026.